Egypt: Alex Pharma posts 87% YoY leap in FY2024/25 net profits

Getty Images/Getty Images

The reported earnings were compared with EGP 216.682 million in FY2023/2024

Staff Writer, Arab Finance

August 11, 2025

PHOTO

Arab Finance: Alexandria Company for Pharmaceuticals and Chemical Industries (Alex Pharma) registered 87.08% higher net profit after tax at EGP 405.374 million in fiscal year (FY) 2024/2025, according to the financial results.

The reported earnings were compared with EGP 216.682 million in FY2023/2024.

Revenue climbed by 56.07% year-on-year (YoY) to EGP 2.773 billion at the end of June 2025 from EGP 1.777 billion.

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

ZAWYA NEWSLETTERS

RELATED ARTICLES

ZAWYA NEWSLETTERS

LATEST VIDEO